Search
Avidity Biosciences Inc
RNAAdd to Watchlist
13.480USD
-0.230-1.68%
Close 08-20 16:00（ET）
1.63BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
T. Rowe Price Associates, Inc.
9.08%
The Vanguard Group, Inc.
5.71%
Vanguard Capital Management, LLC
3.66%
BlackRock Institutional Trust Company, N.A.
2.48%
Vanguard Portfolio Management, LLC
2.01%
Other
77.06%
Shareholders
Shareholders
Proportion
T. Rowe Price Associates, Inc.
9.08%
The Vanguard Group, Inc.
5.71%
Vanguard Capital Management, LLC
3.66%
BlackRock Institutional Trust Company, N.A.
2.48%
Vanguard Portfolio Management, LLC
2.01%
Other
77.06%
Shareholder Types
Shareholders
Proportion
Investment Advisor
25.83%
Individual Investor
4.27%
Investment Advisor/Hedge Fund
3.09%
Bank and Trust
0.13%
Pension Fund
0.05%
Insurance Company
0.02%
Research Firm
0.02%
Other
66.59%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
102
4.97M
29.04%
+3.65M
2025Q4
583
152.91M
98.84%
-7.85M
2025Q3
513
144.57M
99.88%
-1.36M
2025Q2
498
141.72M
117.38%
-3.41M
2025Q1
508
142.16M
117.97%
-7.67M
2024Q4
492
135.01M
112.33%
-12.86M
2024Q3
467
132.62M
112.76%
+3.34M
2024Q2
414
118.94M
111.18%
+14.23M
2024Q1
365
96.48M
102.78%
+1.47M
2023Q4
345
83.09M
112.13%
-13.56M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
772.23K
4.51%
+772.23K
--
Feb 28, 2026
BlackRock Institutional Trust Company, N.A.
8.76K
0.05%
+8.76K
--
Feb 28, 2026
Boyce (Sarah)
265.09K
1.55%
+265.09K
--
Feb 26, 2026
Gallagher (Kathleen P)
28.86K
0.17%
+28.86K
--
Feb 26, 2026
Charles Schwab Investment Management, Inc.
33.70K
0.2%
+33.70K
--
Feb 28, 2026
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Return Stacked Bonds & Merger Arbitrage ETF
11.96%
Global X Genomics & Biotechnology ETF
7.84%
ALPS Medical Breakthroughs ETF
4.27%
State Street SPDR S&P Biotech ETF
3.4%
ProShares Merger ETF
2.74%
Direxion Daily S&P Biotech Bull 3X Shares
1.82%
Virtus LifeSci Biotech Clinical Trials ETF
1.47%
AltShares Event-Driven ETF
1.46%
ProShares Ultra Nasdaq Biotechnology
1.12%
Invesco Nasdaq Biotechnology ETF
0.87%
View more
Return Stacked Bonds & Merger Arbitrage ETF
Proportion11.96%
Global X Genomics & Biotechnology ETF
Proportion7.84%
ALPS Medical Breakthroughs ETF
Proportion4.27%
State Street SPDR S&P Biotech ETF
Proportion3.4%
ProShares Merger ETF
Proportion2.74%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion1.82%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion1.47%
AltShares Event-Driven ETF
Proportion1.46%
ProShares Ultra Nasdaq Biotechnology
Proportion1.12%
Invesco Nasdaq Biotechnology ETF
Proportion0.87%